Upstream Bio, Inc.
NASDAQ:UPBBiotechnology
+$0.10 today
- Market cap
- $114.01M
- Beta
- 1.11
- P/E (TTM)
- -2.2
- EPS (TTM)
- -$2.89
Volume 1.24M
Average 0.66M
UPB Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
Upstream Bio, Inc.NASDAQ: UPB
Gross Margin · Q1 FY2026 · quarter ended Mar 2026
Gross margin narrows to 95.3%
Gross margin was 95.3% in Q1 FY2026, down 4.7 pp from a year earlier. On a trailing-twelve-month basis it was 98.5%, down 1.5 pp year over year. Over 3 fiscal years it widened by 0.0 pp.
Context
- Gross margin widened in 0 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 100.0%
- Year-over-year change
- +0.0pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 100.0% | +0.0pp |
| FY2024 | 2024-12-31 | 100.0% | +0.0pp |
| FY2023 | 2023-12-31 | 100.0% | +0.0pp |
| FY2022 | 2022-12-31 | 100.0% | — |
Gross Margin vs competitors
How UPB compares with its peers on the latest reported figures
- UPB's LTM Mar 2026 gross margin of 98.5% is the 2nd highest of the 8 companies compared; the peer median is 84.6%.
- Its year-over-year change of -1.5 pp is the 5th highest of 7, against a peer median of +124.0 pp.
- Over three fiscal years its change of +0.0 pp compares with a peer median of +20.6 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| FY2025 | 100.0% | +2782.8 pp | — | |
UPBUpstream Bio, Inc. | LTM Mar 2026 | 98.5% | -1.5 pp | +0.0 pp |
| LTM Mar 2026 | 98.0% | -0.0 pp | — | |
| LTM Mar 2026 | 93.8% | -4.1 pp | -20.7 pp | |
| LTM Mar 2026 | 84.6% | -2.8 pp | +50.1 pp | |
| LTM Sep 2026 | 50.0% | — | — | |
| LTM Mar 2026 | -153.7% | +248.0 pp | -9.0 pp | |
| LTM Jun 2026 | -566.6% | +1757.0 pp | +17573.1 pp | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| Peer median (excluding UPB) | 84.6% | +124.0 pp | +20.6 pp | |
Competitors are the stored peer set for UPB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 1.21M | 2.38M | 2.37M | 2.85M |
| Cost of Revenue | 0 | 0 | 0 | 0 |
| Gross Profit | 1.21M | 2.38M | 2.37M | 2.85M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% |
| Research & Development | 18.66M | 31.8M | 62.97M | 136.81M |
| Selling, General & Admin | 6.46M | 10.7M | 17.17M | 26.41M |
| Operating Expenses | 25.12M | 42.49M | 80.13M | 163.22M |
| Depreciation & Amortization | 7K | 60K | 89K | 188K |
| EBITDA | (23.86M) | (20.48M) | (62.72M) | (143.26M) |
| EBITDA Margin | -1968.7% | -860.4% | -2646.3% | -5019.4% |
| Operating Income | (23.91M) | (40.11M) | (77.76M) | (160.36M) |
| Operating Margin | -1972.7% | -1685.5% | -3281.2% | -5618.8% |
| Interest Income | 205K | 4.17M | 12.12M | 16.93M |
| Interest Expense | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 41K | 19.58M | 14.96M | 16.92M |
| Income Before Tax | (23.87M) | (20.54M) | (62.81M) | (143.44M) |
| Pre-Tax Margin | -1969.3% | -862.9% | -2650.0% | -5026.0% |
| Income Tax Expense | 0 | 0 | 0 | 0 |
| Net Income | (23.87M) | (20.54M) | (62.81M) | (143.44M) |
| Net Margin | -1969.3% | -862.9% | -2650.0% | -5026.0% |
| EPS (Basic) | (0.66) | (1.05) | (1.49) | (2.66) |
| EPS (Diluted) | (0.66) | (1.05) | (1.49) | (2.66) |
| Weighted Avg Shares | 36.32M | 36.32M | 51.34M | 53.85M |
| Weighted Avg Shares (Diluted) | 36.32M | 36.32M | 51.34M | 53.85M |
Upstream Bio, Inc.
NASDAQ:UPB
Intrinsic Alpha fair value
Locked
Current Price
$2.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.